A kind of preparation method of saxagliptin intermediate
A technology of intermediate and reaction time, which is applied in the field of preparation of saxagliptin intermediate, can solve the problem of long route and achieve the effects of short route, pollution-free yield and pollution-free industrial production
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] Add (S)-1-N-tert-butoxycarbonyl-2,3-dihydro-2-pyrrolecarboxamide (5.0g, 23.6mmol) and a chiral catalyst (0.15 g) and 30.0g of dichloromethane, reacted at room temperature 25°C for 12h, filtered to remove the catalyst, and then concentrated the organic phase. After removing the solvent, the concentrate was recrystallized with ethyl acetate / n-hexane=1:2 (volume ratio) , freeze-dried after suction filtration to obtain 4.50 g (theoretical 5.33 g) of the product, the ee value was 97%, and the yield was 84.4%.
Embodiment 2
[0044]Add (S)-1-N-tert-butoxycarbonyl-2,3-dihydro-2-pyrrolecarboxamide (5.0g, 23.6mmol) and the chiral Catalyst (0.1g) and 35.0g dichloromethane, after room temperature 25 ℃ reaction 12h, remove catalyst by filtration first, organic phase is concentrated again, after removing solvent, concentrate is ethyl acetate / n-hexane=1:2 (volume ratio ) recrystallization, suction filtration and freeze-drying to obtain 5.15 g (theoretical 5.33 g) of the product, the ee value was 99.5%, and the yield was 96.6%.
Embodiment 3
[0046] Add (S)-1-N-tert-butoxycarbonyl-2,3-dihydro-2-pyrrolecarboxamide (5.0g, 23.6mmol) and the chiral Catalyst (0.1g) and 20.0g dichloromethane, after reacting at 0°C for 30h, first filter to remove the catalyst, and then concentrate the organic phase. After removing the solvent, the concentrate is mixed with ethyl acetate / n-hexane=1:2 (volume ratio) After recrystallization, suction filtration and freeze-drying, 4.9 g of the product (theoretical 5.33 g) was obtained, the ee value was 98%, and the yield was 92.0%.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


